Average Co-Inventor Count = 9.23
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (8 from 3,923 patents)
2. Cell Pathways (2 from 75 patents)
3. Novartis Vaccines & Diagnostics, Gmbh (1 from 245 patents)
11 patents:
1. 12071441 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
2. 11629149 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
3. 11072610 - Antiviral pyridopyrazinedione compounds
4. 10660888 - Aminoheteroaryl benzamides as kinase inhibitors
5. 10188649 - Aminoheteroaryl benzamides as kinase inhibitors
6. 10160726 - Quinolone derivatives as antibacterials
7. 9763937 - Aminoheteroaryl benzamides as kinase inhibitors
8. 9242996 - Aminoheteroaryl benzamides as kinase inhibitors
9. 7470701 - Substituted 2,5-heterocyclic derivatives
10. 6486158 - [4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia
11. 6180629 - [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia